[Factors predicting lack of adherence to highly active antiretroviral treatment]

Enferm Infecc Microbiol Clin. 2002 Dec;20(10):491-7. doi: 10.1016/s0213-005x(02)72851-6.
[Article in Spanish]

Abstract

Introduction: Knowledge of adherence to highly active antiretroviral treatment (HAART) and the variables associated with poor compliance is useful for the follow-up of HIV infected patients.

Patients, material and methods: Patients were consecutively recruited from the HIV outpatient clinics of the Hospitals of Leon and El Bierzo from January to June 2000. Patients were considered non-adherent to treatment if they failed to take 10% or more of their prescribed total dose of at least one drug during the 4 days before the interview, or if they had accumulated a delay of more than 9 days over the previous 3 months in picking up their prescribed drugs from the hospital pharmacy. Logistic regression analysis was performed with variables found to be associated with adherence in the univariate analysis.

Results: The methods used to determine adherence had a Kappa index of 12.6%. Among the 206 patients interviewed, 108 were considered non-adherent (52.4%; CI 95% 5 45.6-59.2). Multivariate analysis showed that the following factors were associated with poor treatment adherence: cocaine consumption in the previous six months (adjusted OR 5 5.1); patients unsure about the proper way to take prescribed treatment; (adjusted OR 5 2.5); and patients not prescribed the zidovudine-lamivudine combination (adjusted OR 5 1.9). Over one-third of patients with no variable associated with treatment adherence were considered non-compliant.

Conclusion: Measurement of medication adherence and its predictive factors involved methodological difficulties. With the criteria used in the present study more than half the patients were considered non-compliant. The variables found to be related to poor adherence can be modified by social, psychological or health care interventions.

Publication types

  • English Abstract
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-HIV Agents / therapeutic use*
  • Antiretroviral Therapy, Highly Active / methods
  • Antiretroviral Therapy, Highly Active / statistics & numerical data*
  • Antiretroviral Therapy, Highly Active / trends
  • Data Collection
  • Drug Combinations
  • Drug Utilization Review / methods
  • HIV Infections / drug therapy*
  • Humans
  • Lamivudine / therapeutic use
  • Outpatient Clinics, Hospital / statistics & numerical data
  • Patient Compliance / statistics & numerical data
  • Patient Dropouts / statistics & numerical data
  • Registries / statistics & numerical data
  • Sensitivity and Specificity
  • Spain
  • Treatment Refusal / statistics & numerical data
  • Zidovudine / therapeutic use

Substances

  • Anti-HIV Agents
  • Drug Combinations
  • Lamivudine
  • Zidovudine